Genotype/phenotype correlation studies of the short ERCC3(XPB) patient cohort have suggested that partially active missense mutations may explain symptoms in milder patients, whilst severe XP/CS complex patients have nonsense or consensus splice mutations with low levels of altered XPB proteins. This evidence concerns the gene ERCC3 and xeroderma pigmentosum.